4

PRIMARY DOCUMENT

Company: ENDONOVO THERAPEUTICS, INC.
Filed: February 5, 2019
Period of Report: January 30, 2019
Accession Number: 0001645470-19-000008

View Document ↗ View on SEC.gov ↗